Non-nucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2006261954 (hide)

Owner Merck & Co., Inc.

Inventors Lindsley, Craig W.; Leister, William H.; Wolkenberg, Scott E.

Agent Spruson & Ferguson

Pub. Number AU-A-2006261954

PCT Pub. Number WO2007/002481

Priority 60/707,365 11.08.05 US; 60/694,744 28.06.05 US

Filing date 23 June 2006

Wipo publication date 4 January 2007

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002481 Priority application(s): WO2007/002481

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261964-Coiled tubing/top drive rig and method

2006261953-Systems and methods including selfcontained cartridges with detection systems and fluid delivery systems